Cargando…

Synaptotagmin 13 is neuroprotective across motor neuron diseases

In amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA), spinal and lower brainstem motor neurons degenerate, but some motor neuron subtypes are spared, including oculomotor neurons (OMNs). The mechanisms responsible for this selective degeneration are largely unknown, but the molec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nizzardo, M., Taiana, M., Rizzo, F., Aguila Benitez, J., Nijssen, J., Allodi, I., Melzi, V., Bresolin, N., Comi, G. P., Hedlund, E., Corti, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181443/ https://www.ncbi.nlm.nih.gov/pubmed/32065260 http://dx.doi.org/10.1007/s00401-020-02133-x

Ejemplares similares

Stathmins and Motor Neuron Diseases: Pathophysiology and Therapeutic Targets
por: Gagliardi, Delia, et al.
Publicado: (2022)

Modeling Motor Neuron Resilience in ALS Using Stem Cells
por: Allodi, Ilary, et al.
Publicado: (2019)

Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS
por: Allodi, Ilary, et al.
Publicado: (2016)

Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons
por: Rizzo, Federica, et al.
Publicado: (2019)

MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors
por: Rizzuti, Mafalda, et al.
Publicado: (2018)

Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown–Vialetto disease that is partially rescued by riboflavin
por: Rizzo, Federica, et al.
Publicado: (2017)

Investigation of New Morpholino Oligomers to Increase Survival Motor Neuron Protein Levels in Spinal Muscular Atrophy
por: Ramirez, Agnese, et al.
Publicado: (2018)

Spinal muscular atrophy with respiratory distress type 1: Clinical phenotypes, molecular pathogenesis and therapeutic insights
por: Saladini, Matteo, et al.
Publicado: (2019)

Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches
por: Nizzardo, Monica, et al.
Publicado: (2015)

iPSC-Derived Neural Stem Cells Act via Kinase Inhibition to Exert Neuroprotective Effects in Spinal Muscular Atrophy with Respiratory Distress Type 1
por: Simone, Chiara, et al.
Publicado: (2014)

Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis
por: Nijssen, Jik, et al.
Publicado: (2017)

Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes
por: Rizzuti, Mafalda, et al.
Publicado: (2022)

Axon-Seq Decodes the Motor Axon Transcriptome and Its Modulation in Response to ALS
por: Nijssen, Jik, et al.
Publicado: (2018)

Animal Models of CMT2A: State-of-art and Therapeutic Implications
por: De Gioia, Roberta, et al.
Publicado: (2020)

Direct reprogramming of human astrocytes into neural stem cells and neurons
por: Corti, Stefania, et al.
Publicado: (2012)

Neural Stem Cell Transplantation for Neurodegenerative Diseases
por: De Gioia, Roberta, et al.
Publicado: (2020)

Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot–Marie–Tooth type 2A
por: Rizzo, Federica, et al.
Publicado: (2023)

The highly expressed calcium‐insensitive synaptotagmin‐11 and synaptotagmin‐13 modulate insulin secretion
por: Ofori, Jones K., et al.
Publicado: (2022)

Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model
por: Nizzardo, Monica, et al.
Publicado: (2014)

Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype
por: Nizzardo, M., et al.
Publicado: (2016)

Molecular, genetic and stem cell-mediated therapeutic strategies for spinal muscular atrophy (SMA)
por: Zanetta, Chiara, et al.
Publicado: (2014)

Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
por: Rizzo, Federica, et al.
Publicado: (2013)

LCM-seq reveals unique transcriptional adaptation mechanisms of resistant neurons and identifies protective pathways in spinal muscular atrophy
por: Nichterwitz, Susanne, et al.
Publicado: (2020)

iPSC-Based Models to Unravel Key Pathogenetic Processes Underlying Motor Neuron Disease Development
por: Faravelli, Irene, et al.
Publicado: (2014)

Architecture of the Synaptotagmin-SNARE Machinery for Neuronal Exocytosis
por: Zhou, Qiangjun, et al.
Publicado: (2015)

Targeting PTB for Glia-to-Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases
por: Contardo, Matilde, et al.
Publicado: (2022)

Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model
por: Nizzardo, Monica, et al.
Publicado: (2015)

Motor neuron derivation from human embryonic and induced pluripotent stem cells: experimental approaches and clinical perspectives
por: Faravelli, Irene, et al.
Publicado: (2014)

Synaptotagmin-13 Is a Neuroendocrine Marker in Brain, Intestine and Pancreas
por: Tarquis-Medina, Marta, et al.
Publicado: (2021)

Synaptotagmin-13 orchestrates pancreatic endocrine cell egression and islet morphogenesis
por: Bakhti, Mostafa, et al.
Publicado: (2022)

Cell-penetrating peptide-conjugated Morpholino rescues SMA in a symptomatic preclinical model
por: Bersani, Margherita, et al.
Publicado: (2022)

Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases
por: Abati, Elena, et al.
Publicado: (2022)

Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies
por: Salani, Sabrina, et al.
Publicado: (2012)

Synaptotagmin 13 Is Highly Expressed in Estrogen Receptor-Positive Breast Cancer
por: Ichikawa, Takahiro, et al.
Publicado: (2021)

Directed midbrain and spinal cord neurogenesis from pluripotent stem cells to model development and disease in a dish
por: Allodi, Ilary, et al.
Publicado: (2014)

Synaptotagmin Function Illuminated
por: Lindau, Manfred
Publicado: (2003)

Synergistic roles of Synaptotagmin-1 and complexin in calcium-regulated neuronal exocytosis
por: Ramakrishnan, Sathish, et al.
Publicado: (2020)

Synaptotagmin-1 is a bidirectional Ca(2+) sensor for neuronal endocytosis
por: Chen, Yang, et al.
Publicado: (2022)

Tyr78Phe Transthyretin Mutation with Predominant Motor Neuropathy as the Initial Presentation
por: Riboldi, Giulietta, et al.
Publicado: (2011)

Molecular analysis of SMARD1 patient-derived cells demonstrates that nonsense-mediated mRNA decay is impaired
por: Taiana, Michela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_67d2j7jq76rp087i6o0bsv0uto